netFormulary
 Report : A-Z HCD items in Formulary 06/10/2024 00:24:14
[Back]
 
Section Status HCD Name
10.01.03 Formulary Cancer Drugs Fund Abatacept Orencia®
10.01.03 Formulary Cancer Drugs Fund Adalimumab Biosimilars avaliable
13.05.03 Formulary Cancer Drugs Fund Adalimumab Biosimilars avaliable
11.08.02 Formulary Cancer Drugs Fund Aflibercept Eylea®
13.05.01 Formulary Cancer Drugs Fund Alitretinoin Toctino®
10.01.03 Formulary Cancer Drugs Fund Anakinra Kineret®
13.05.03 Formulary Cancer Drugs Fund Apremilast Otezla®
10.01.03 Formulary Cancer Drugs Fund Baricitinib Olumiant®
10.01 Formulary Cancer Drugs Fund Belimumab Benlysta®
03.04.02 Formulary Cancer Drugs Fund Benralizumab Fasenra®
03.04.03 Formulary Cancer Drugs Fund Berotralstat dihydrochloride Orladeyo®
04.07.04.02 Formulary Cancer Drugs Fund Botulinum Toxin Type A botox®
13.05.03 Formulary Cancer Drugs Fund Brodalumab Kyntheum®
10.01.03 Formulary Cancer Drugs Fund Certolizumab Pegol Cimzia®
09.01.03 Formulary Cancer Drugs Fund Deferasirox Exjade®
09.01.03 Formulary Cancer Drugs Fund Deferiprone Ferriprox®
11.04.01 Formulary Cancer Drugs Fund Dexamethasone intravitreal implant Ozurdex®
13.05.03 Formulary Cancer Drugs Fund Dupilumab Dupixent®
09.01.04 Formulary Cancer Drugs Fund Eltrombopag Revolade®
02.08.01 Formulary Cancer Drugs Fund Epoprostenol 
10.01.03 Formulary Cancer Drugs Fund Etanercept Biosimilars avaliable
13.05.03 Formulary Cancer Drugs Fund Etanercept Biosimilars avaliable
11.04.01 Formulary Cancer Drugs Fund Fluocinolone intravitreal implant Iluvien®
11.03.01 Formulary Cancer Drugs Fund Fusidic Acid 
10.01.03 Formulary Cancer Drugs Fund Golimumab Simponi®
10.01.03 Formulary Cancer Drugs Fund Infliximab Biosimilars avaliable
13.05.03 Formulary Cancer Drugs Fund Infliximab Biosimilars avaliable
13.05.02 Formulary Cancer Drugs Fund Ixekizumab  Taltz®
09.05.02.02 Formulary Cancer Drugs Fund Lanthanum Fosrenol ®
11.08.02 Formulary Cancer Drugs Fund Ranibizumab 
04.09.03 Formulary Cancer Drugs Fund Riluzole Rilutek®
10.01.03 Formulary Cancer Drugs Fund Risankizumab Skyrizi®
13.05.03 Formulary Cancer Drugs Fund Risankizumab Skyrizi®
09.01.03 Formulary Cancer Drugs Fund Rituximab 
09.01.04 Formulary Cancer Drugs Fund Rituximab idiopathic thrombocytopenia in adults
10.01.03 Formulary Cancer Drugs Fund Rituximab (rheumatology) Biosimilars avaliable
09.01.04 Formulary Cancer Drugs Fund Romiplostim Nplate®
10.01.03 Formulary Cancer Drugs Fund Sarilumab Kevzara®
13.05.03 Formulary Cancer Drugs Fund Secukinumab Cosentyx®
06.05.01 Formulary Cancer Drugs Fund Somatropin 
06.06.01 Formulary Cancer Drugs Fund Teriparatide 
13.05.03 Formulary Cancer Drugs Fund Tildrakizumab Ilumetri®
10.01.03 Formulary Cancer Drugs Fund Tocilizumab Biosimilars avaliable
06.05.02 Formulary Cancer Drugs Fund Tolvaptan 
13.05.03 Formulary Cancer Drugs Fund Ustekinumab Stelara®
Lancashire and South Cumbria